🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Softgel(s) Serving Size
300 Servings
Non-Nutrient/Non-Botanical Product Type
50% Evidence Coverage

Supplement Facts — Evidence Check

8800 mcg
📊 Market median: 10.0mg (105 products) 📚 1 studies (Tier A: 0, B: 1)
This product: 8.8mg
200 mcg
📊 Market median: 4.0mg (32 products)
This product: 0.2mg

Other Ingredients

Soybean Oil Gelatin Glycerin Water, Purified Beeswax

Label Claims — Verification

All Other
Structure/Function
All Other (100% of products) Structure/Function (100% of products) Nutrient (18% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Suggested use: As a dietary supplement, take 1 softgel once daily, or as directed by a physician.

⚠️ Warnings & Precautions

Allergen information: Soy

Always consult a physician before taking any dietary supplement.

Keep out of reach of children.

🧪 Formulation Notes

Free of: Dairy, yeast, gluten

Additional Information

Store in a cool, dry place.

Product Details

DSLD Entry Date 2023-07-18
Product Type Non-Nutrient/Non-Botanical
Form Softgel Capsule
DSLD ID 294414
Data Updated 2026-04-11

Research Evidence

5 Research Sources
45 Avg Quality Score
3 Rct
2 Clinical Trial
C No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18
Rct Ophthalmology 2019
C Effect of Dietary Supplementation with Lutein, Zeaxanthin, and Elderberries on Dry Eye Disease (DED) and Immunity: A Randomized Controlled Trial.
Rct Nutrients
C Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration.
Rct Ophthalmology
C The Effects of a Zeaxanthin Intervention on Visuomotor Function
Clinical Trial ClinicalTrials.gov 2012
D Lutein/Zeaxanthin and Omega-3 Supplementation in Persons Over Age 60
Clinical Trial ClinicalTrials.gov 2005
View all evidence for Zeaxanthin →

Compare Similar Products

View all Zeaxanthin products →